A detailed history of Bard Associates Inc transactions in Nephros Inc stock. As of the latest transaction made, Bard Associates Inc holds 172,371 shares of NEPH stock, worth $253,385. This represents 0.11% of its overall portfolio holdings.

Number of Shares
172,371
Previous 175,596 1.84%
Holding current value
$253,385
Previous $370,000 20.54%
% of portfolio
0.11%
Previous 0.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$1.71 - $2.29 $5,514 - $7,385
-3,225 Reduced 1.84%
172,371 $294,000
Q2 2024

Aug 12, 2024

SELL
$1.99 - $2.36 $7,522 - $8,920
-3,780 Reduced 2.11%
175,596 $370,000
Q1 2024

May 13, 2024

SELL
$2.11 - $3.78 $16,757 - $30,020
-7,942 Reduced 4.24%
179,376 $392,000
Q4 2023

Feb 13, 2024

BUY
$1.46 - $3.91 $1,867 - $5,000
1,279 Added 0.69%
187,318 $648,000
Q3 2023

Nov 13, 2023

SELL
$1.35 - $1.72 $9,315 - $11,868
-6,900 Reduced 3.58%
186,039 $275,000
Q2 2023

Aug 11, 2023

SELL
$1.14 - $2.02 $1,538 - $2,727
-1,350 Reduced 0.69%
192,939 $299,000
Q1 2023

May 12, 2023

SELL
$0.97 - $1.35 $485 - $675
-500 Reduced 0.26%
194,289 $207,000
Q4 2022

Feb 10, 2023

SELL
$0.93 - $1.25 $53,321 - $71,668
-57,335 Reduced 22.74%
194,789 $225,000
Q3 2022

Nov 09, 2022

SELL
$0.91 - $1.87 $10,583 - $21,748
-11,630 Reduced 4.41%
252,124 $229,000
Q2 2022

Aug 11, 2022

BUY
$1.47 - $4.63 $25,498 - $80,311
17,346 Added 7.04%
263,754 $404,000
Q1 2022

May 11, 2022

BUY
$3.89 - $6.12 $54,071 - $85,068
13,900 Added 5.98%
246,408 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$5.87 - $8.46 $9,979 - $14,382
-1,700 Reduced 0.73%
232,508 $1.37 Million
Q3 2021

Nov 12, 2021

BUY
$7.6 - $10.01 $20,520 - $27,027
2,700 Added 1.17%
234,208 $2.05 Million
Q2 2021

Aug 12, 2021

BUY
$6.61 - $10.68 $80,179 - $129,548
12,130 Added 5.53%
231,508 $2.35 Million
Q1 2021

May 13, 2021

BUY
$6.65 - $8.93 $83,324 - $111,892
12,530 Added 6.06%
219,378 $1.46 Million
Q4 2020

Feb 11, 2021

BUY
$5.86 - $8.58 $29,593 - $43,329
5,050 Added 2.5%
206,848 $1.78 Million
Q3 2020

Nov 12, 2020

SELL
$5.58 - $8.45 $3,744 - $5,669
-671 Reduced 0.33%
201,798 $1.46 Million
Q2 2020

Aug 13, 2020

SELL
$6.15 - $9.35 $31,365 - $47,685
-5,100 Reduced 2.46%
202,469 $1.7 Million
Q1 2020

May 13, 2020

BUY
$5.99 - $10.29 $1.24 Million - $2.14 Million
207,569 New
207,569 $2.64 Million

Others Institutions Holding NEPH

About NEPHROS INC


  • Ticker NEPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 10,318,800
  • Market Cap $15.2M
  • Description
  • Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...
More about NEPH
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.